Prescription and over-the-counter medicine
Mometasone Brand names: Allergy, Asmanex, Nasonex, Sinuva, Topcare; first approved as Elocon
Mometasone (Allergy) is a prescription and over-the-counter medicine with an FDA approval on record since 1987. FDA's NDC Directory lists it from 16 generic labelers, and pharmacies paid $0.354 per gram (Mometasone furoate 0.1% cream) in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the mometasone FDA label on DailyMed (effective August 19, 2026, L. Perrigo Company); the NDA 19543 record on Drugs@FDA; every mometasone label on DailyMed.
Highlights of the record
FDA label of August 19, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usagetemporarily relieves these symptoms of hay fever or other upper respiratory allergies:
nasal congestion
runny nose
sneezing
itchy nose
Forms and strengths
- 1 mg
- 1 mg/g
- 1 mg/ml
Spray (metered); cream; ointment; solution; aerosol.
On the market
- Earliest approval on file
- April 30, 1987 Elocon, Organon; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 25 first March 18, 2002; 14 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 27 of which 16 under generic applications, 11 under brand applications, repackagers included
- Last listed patent
- November 24, 2034 Sinuva implant; not a generic launch date
Supply and safety
- Pharmacy cost (NADAC)
- $0.354 per gram Mometasone furoate 0.1% cream
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 8 since 2014 0 Class I among all firms' recalls; latest May 28, 2024; 1 more by firms not listed as its makers
- FAERS reports
- 41,531 through July 30, 2026
What is mometasone used for?
From the label: indications and usagetemporarily relieves these symptoms of hay fever or other upper respiratory allergies:
nasal congestion
runny nose
sneezing
itchy nose
Conditions named in the indications of mometasone's FDA labels, with every medicine labeled for each:
From other mometasone labelsAllergies: Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies:
Asthma: Maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. ( 1.1 ) Important limitations:
FDA pharmacologic class: Corticosteroid.
Source: FDA drug label (Nasonex), L. Perrigo Company, effective August 19, 2026 (SPL set 13696a8b-366a-4a5e-adea-d5b7bff9e46f), via openFDA; the full label on DailyMed
What does the patient leaflet for mometasone say first?
The FDA-approved Medication Guide or Patient Information that comes with the medicine, in its own words.
From the patient leaflet: What should I avoid while taking mometasone furoate monohydrate nasal spray?If you are taking other corticosteroid medicines for allergy, by mouth or injection, your healthcare provider may advise you to stop taking them after you begin using mometasone furoate monohydrate nasal spray.
From the patient leaflet: How should I store mometasone furoate monohydrate nasal spray?Store mometasone furoate monohydrate nasal spray at room temperature between 59 o F to 86 o F (15 o C to 30 o C). Protect from light. Avoid prolonged exposure of mometasone furoate monohydrate nasal spray container to direct light. Shake well before each use. Keep mometasone furoate monohydrate nasal spray and all medicines out of the reach of children.
Source: FDA drug label (MOMETASONE FUROATE MONOHYDRATE), Aurobindo Pharma Limited, effective March 19, 2024 (SPL set b24f80c5-afe2-4821-9185-2dad3cfe277a), via openFDA; the full label on DailyMed
Is there a generic for mometasone (Allergy)?
The FDA approved the first generic mometasone on March 18, 2002. 25 generic applications are approved; 14 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists mometasone from 16 labelers under a generic (ANDA) application and from 11 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
The Orange Book lists no patent for Nasonex 24Hr Allergy spray; a patent listed only for Sinuva implant runs to November 24, 2034. A patent or exclusivity date is not the date a generic goes on sale: court cases and settlements move it either way.
- 1987 earliest approval on file
- 2002 first generic approved
- 2034 last listed patent
- red ticks recalls
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for mometasone (Allergy)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.354 per gram (Mometasone furoate 0.1% cream), down 3% from $0.366 on October 8, 2025. Prices per unit in the table differ many-fold by strength, form and brand, so compare like with like. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Mometasone furoate 0.1% ointment (generic)
- Nasonex 24hr allergy 50 mcg nasal spray (brand)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Allergy nasal 50 mcg spray | Generic | $0.714 per mL | n/a | no change |
| Mometasone furoate 0.1% cream | Generic | $0.354 per gram | n/a | -3% |
| Mometasone furoate 0.1% ointment | Generic | $0.250 per gram | n/a | -9% |
| Mometasone furoate 0.1% solution | Generic | $0.483 per mL | n/a | +8% |
| Mometasone furoate 50 mcg spry | Generic | $1.59 per gram | n/a | -10% |
| Asmanex hfa 100 mcg inhaler | Brand | $7.38 per gram | n/a | -0.2% |
| Asmanex hfa 200 mcg inhaler | Brand | $8.67 per gram | n/a | -0.2% |
| Asmanex hfa 50 mcg inhaler | Brand | $6.84 per gram | n/a | -0.1% |
| Asmanex twisthaler 110 mcg #30 | Brand | $88.83 per unit | n/a | -0.2% |
| Asmanex twisthaler 220 mcg #14 | Brand | $36.98 per unit | n/a | +0.1% |
| Asmanex twisthaler 220 mcg #30 | Brand | $96.04 per unit | n/a | no change |
| Asmanex twisthaler 220 mcg #60 | Brand | $112.65 per unit | n/a | -0.1% |
| Asmanex twisthalr 220 mcg #120 | Brand | $161.43 per unit | n/a | -0.2% |
| Nasonex 24hr allergy 50 mcg nasal spray | Brand | $1.23 per mL | n/a | +2% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
Has mometasone been recalled?
The FDA's Enforcement Report lists 9 recalls naming mometasone since 2014: 0 Class I (the most serious), 3 Class II, 6 Class III; 2 still ongoing. 1 of them is by a firm that FDA's NDC Directory does not list as a maker of mometasone and that holds no application for it in Drugs@FDA, such as compounding pharmacies or bulk-ingredient suppliers; the recall notice names the product recalled. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| May 28, 2024 | Class III | Organon Llc | Defective Container |
| January 4, 2023 | Class III | Intersect ENT, Inc. | Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months. |
| June 16, 2022 | Class III | Glenmark Pharmaceuticals Inc., USA | Defective Container |
| January 26, 2022 | Class II | CARDINAL HEALTHCARE | CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. |
| July 23, 2019 | Class II | Glenmark Pharmaceuticals Inc., USA | GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty. |
| February 7, 2019 | Class III | ACP Nimble Buyer, Inc. | Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error. |
| July 13, 2015 | Class III | Perrigo Israel Pharmaceuticals | Subpotent drug |
| May 30, 2014 | Class II | Brookfield Prescription Center Inc. dba MD Custom Rx not a listed maker | Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the mometasone label say about other medicines?
The mometasone label names 9 other medicines in its interaction, contraindication or warning sections. The labels of 15 other medicines name mometasone. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Albuterol | warnings and precautions | When prescribing ASMANEX HFA, the physician must also provide the patient with an inhaled, short-acting beta 2 -agonist (e.g., albuterol) for treatment of acute symptoms, despite regular twice-daily (morning and evening) use of ASMANEX HFA. |
| Atazanavir | drug interactions (prescription label) | Caution should be exercised when considering the coadministration of mometasone furoate monohydrate nasal spray with long-term ketoconazole and other known strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir … |
| Clarithromycin | drug interactions (prescription label) | Caution should be exercised when considering the coadministration of mometasone furoate monohydrate nasal spray with long-term ketoconazole and other known strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir … |
| Itraconazole | drug interactions (prescription label) | … CYP3A4 inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) [see Clinical Pharmacology (12.3) ]. |
| Ketoconazole | drug interactions (prescription label) | Caution should be exercised when considering the coadministration of mometasone furoate monohydrate nasal spray with long-term ketoconazole and other known strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir … |
| Nefazodone | drug interactions (prescription label) | … inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) [see Clinical Pharmacology (12.3) ]. |
| Nelfinavir | drug interactions (prescription label) | … ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) [see Clinical Pharmacology (12.3) ]. |
| Prednisone | warnings and precautions | Patients who have been previously maintained on 20 mg or more per day of prednisone (or its equivalent) may be most susceptible, particularly when their systemic corticosteroids have been almost completely withdrawn. |
| Ritonavir | drug interactions (prescription label) | Caution should be exercised when considering the coadministration of mometasone furoate monohydrate nasal spray with long-term ketoconazole and other known strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat-containing products, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir … |
Other labels that name mometasone
Source: FDA drug label (Nasonex), L. Perrigo Company, effective August 19, 2026 (SPL set 13696a8b-366a-4a5e-adea-d5b7bff9e46f), via openFDA; the full label on DailyMed
What do FAERS reports show for mometasone?
The FDA Adverse Event Reporting System holds 41,531 reports that list mometasone among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1,579 are coded as a death and 10,285 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
How does mometasone compare with medicines for the same use?
7 side-by-side pages set mometasone beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.
What next?
- Other corticosteroids
- the pharmacologic class, with prices and generics
- Mometasone side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other